108 related articles for article (PubMed ID: 883191)
1. [Bone marrow hematopoiesis in lung cancer].
Protasova AK
Vopr Onkol; 1977; 23(4):14-7. PubMed ID: 883191
[TBL] [Abstract][Full Text] [Related]
2. [Lung cancer with an increase in macrophages displaying marked hemophagocytosis in the bone marrow].
Narumi S; Nozaki H
Rinsho Ketsueki; 1985 Jan; 26(1):58-62. PubMed ID: 3999399
[No Abstract] [Full Text] [Related]
3. [Detection of circulating tumor cells by nano-immunomagnetic enrichment in early lung cancer].
Wang XG; Hu H; Liu YN
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1393-5. PubMed ID: 15637821
[No Abstract] [Full Text] [Related]
4. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of neoplasm metastases to the bone marrow in patients with lung cancer].
Dziecioł J; Kemona A; Sulik M; Sobaniec-Lotowska M; Sulkowski S; Ostapiuk H; Pasztaleniec L; Deregowski K
Pneumonol Pol; 1989 Apr; 57(4):235-9. PubMed ID: 2560829
[TBL] [Abstract][Full Text] [Related]
6. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
9. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and IL-2R in lung cancer.
Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
[TBL] [Abstract][Full Text] [Related]
11. [A method of detecting atypical cells in the blood of lung cancer patients].
Sergel' OS; Adamian AA; Kachkov AP
Eksp Khir Anesteziol; 1969; 14(6):39-44. PubMed ID: 4318160
[No Abstract] [Full Text] [Related]
12. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer].
Fujii M; Ishikawa M; Toki H
Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756
[TBL] [Abstract][Full Text] [Related]
13. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
14. [Clinical importance of the method of absolute magakaryocyte count in the trephine for the evaluation of the state of hematopoiesis in oncological patients].
Sukhanov IuS
Probl Gematol Pereliv Krovi; 1976 May; 21(5):57-8. PubMed ID: 1024216
[No Abstract] [Full Text] [Related]
15. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
17. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
18. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
20. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]